We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.08T
AUM Growth
+$79.9B
Cap. Flow
-$8.94B
Cap. Flow %
-0.83%
Top 10 Hldgs %
25.7%
Holding
3,000
New
159
Increased
1,164
Reduced
1,499
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.45B
2
PINS icon
Pinterest
PINS
+$1.89B
3
TMUS icon
T-Mobile US
TMUS
+$1.89B
4
ZM icon
Zoom
ZM
+$1.77B
5
PATH icon
UiPath
PATH
+$1.71B

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$3.66B
2
CAT icon
Caterpillar
CAT
+$1.32B
3
NFLX icon
Netflix
NFLX
+$1.18B
4
MXIM
Maxim Integrated Products
MXIM
+$1.15B
5
MU icon
Micron Technology
MU
+$1.07B

Sector Composition

Rank Sector Weight
1 Technology 24.62%
2 Healthcare 16.07%
3 Consumer Discretionary 15.29%
4 Communication Services 13.46%
5 Financials 12.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNPX icon
2801
Genprex
GNPX
$2.39M
$126K ﹤0.01%
1
LPCN icon
2802
Lipocine
LPCN
$17M
$125K ﹤0.01%
5,251
ZYNE
2803
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$125K ﹤0.01%
23,600
-6,900
-23% -$33.2K
CND
2804
DELISTED
Concord Acquisition Corp.
CND
$125K ﹤0.01%
12,717
+2,717
+27% +$26.7K
LYTS icon
2805
LSI Industries
LYTS
$890M
$124K ﹤0.01%
15,525
-1,763
-10% -$14.8K
PED icon
2806
PEDEVCO
PED
$150M
$124K ﹤0.01%
3,905
WWR icon
2807
Westwater Resources
WWR
$81M
$124K ﹤0.01%
+26,100
New +$118K
AXDX
2808
DELISTED
Accelerate Diagnostics
AXDX
$120K ﹤0.01%
+1,485
New +$118K
CRMD icon
2809
CorMedix
CRMD
$557M
$120K ﹤0.01%
17,527
+912
+5% +$7.26K
AHT
2810
Ashford Hospitality Trust
AHT
$19.8M
$118K ﹤0.01%
+258
New +$93.5K
HYLN icon
2811
Hyliion Holdings
HYLN
$694M
$118K ﹤0.01%
+10,160
New +$106K
NGVC icon
2812
Vitamin Cottage Natural Grocers
NGVC
$632M
$118K ﹤0.01%
11,009
-8,993
-45% -$122K
BRMK
2813
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$118K ﹤0.01%
+11,187
New +$119K
EGY icon
2814
Vaalco Energy
EGY
$602M
$117K ﹤0.01%
35,900
KODK icon
2815
Kodak
KODK
$992M
$116K ﹤0.01%
13,974
+2,469
+21% +$19.4K
APTX
2816
DELISTED
Aptinyx Inc. Common Stock
APTX
$116K ﹤0.01%
+41,121
New +$115K
CEI
2817
DELISTED
Camber Energy, Inc
CEI
$116K ﹤0.01%
+3,506
New +$125K
GROW icon
2818
US Global Investors
GROW
$38.7M
$115K ﹤0.01%
18,600
-37,900
-67% -$270K
JAGX icon
2819
Jaguar Health
JAGX
$3.73M
0
AIOT
2820
PowerFleet Inc
AIOT
$421M
$114K ﹤0.01%
15,900
-2,043
-11% -$14.9K
CBUS icon
2821
Cibus
CBUS
$144M
$113K ﹤0.01%
562
-199
-26% -$47.3K
TCON
2822
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$113K ﹤0.01%
870
-250
-22% -$34.6K
DCH
2823
Dauch Corp
DCH
$1.61B
$112K ﹤0.01%
+10,855
New +$114K
REKR icon
2824
Rekor Systems
REKR
$94M
$110K ﹤0.01%
+10,820
New +$166K
AGRX
2825
DELISTED
Agile Therapeutics
AGRX
$110K ﹤0.01%
41
-3
-7% -$9.89K

Similar funds

T. Rowe Price Associates's Q2 2021 Portfolio in Review

As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
  • T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
  • T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
  • T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
  • T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
  • T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.

Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.